Authors
Loading...
Randomized trial demonstrates protective efficacy of monoclonal antibodies against H10N8 influenza in mice, suggesting new treatment avenues.
Wohlbold et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: